Lymphoma Canada is pleased to announce that they are accepting applications for 2022 research funding until March 31.
These funds are intended to support small, well-defined research studies that have the potential to effect improvements in healthcare, health systems, and/or health outcomes as they pertain to malignant lymphoproliferative diseases.
Proposed research studies may address any of the following broad areas of research, including but not limited to:
- patient-reported outcomes;
- comparative clinical effectiveness;
- pharmaco-economics; or
- health care utilization.
Further information and a link to apply can be found online at: https://www.lymphoma.ca/resources/healthcare-professionals/research-funding/